Kamada logo

Kamada

KMDA | NASDAQ
Chart Builder DCF Calculator
$8.11
+$0.02 (+0.25%)
At close: Nov 16, 2026, 4:00 PM ET
$8.10
-$0.01 (-0.12%)
After-hours: Nov 16, 2026, 7:55 PM ET
+0.25%

Rating

Updated: Nov 16, 2026
72
Fundamentals Excellent
Market Sentiment Neutral
Moat Narrow
Sector Rank #42/1021 (Top 4%)

Key Statistics

Market Data

Market Cap $467.8M
1D Range
8.08 8.25
52W Range
6.68 9.31

Valuation (TTM)

PE 18.86
PB 1.74
EV/EBITDA 8.85

Valuation (NTM)

Forward PE 16.85
Forward PEG 0.58
Price Target $15.00
Loading financial charts...

Profile

Kamada Ltd. is a biopharmaceutical firm focused on developing, manufacturing, and distributing protein therapeutics derived from human plasma. The company operates through two core business areas: its...

Sector Healthcare
Employees 462
IPO Date May 31, 2013
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 9, 2026
EPS
$0.14
Beat +9.80%
REV
$52.03M
Miss -0.90%
Next Earnings
Mar 10, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$15.00
Upside
+84.96%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.